Source: Lab Bulletin

Sphere Fluidics: Sphere Fluidics launches Cyto-Mine Chroma and announces Early Access Program

Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&DSphere Fluidics, a leading provider of innovative picodroplet-based microfluidics solutions for functional single cell analysis and isolation, has announced the launch of Cyto-Mine® Chroma and the opening of its Early Access Program...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Dale Levitzke's photo - CEO of Sphere Fluidics

CEO

Dale Levitzke

CEO Approval Rating

83/100

Read more